ProShare Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $525K | Sell |
|
|||||
|
2025
Q1 | $358K | Sell |
|
|||||
|
2024
Q4 | $655K | Buy |
|
|||||
|
2024
Q3 | $578K | Buy |
|
|||||
|
2024
Q2 | $276K | Sell |
|
|||||
|
2024
Q1 | $467K | Buy |
|
|||||
|
2023
Q4 | $250K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $245K | Sell |
|
|||||
|
2022
Q4 | $235K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $499K | Sell |
|
|||||
|
2021
Q4 | $935K | Buy |
|
|||||
|
2021
Q3 | $259K | Sell |
|
|||||
|
2021
Q2 | $364K | Buy |
|